NEW YORK (GenomeWeb News) – Tecan and JPT Peptide Technologies today announced a deal to co-promote JPT's catalog peptide arrays and profiling capabilities.
Under the terms of the agreement, the companies will co-promote JPT's products alongside Tecan's microarray handling devices. Other terms were not disclosed.
"Providing a high level of data quality and consistency is a burning need in microarray research," Siegfried Sasshofer, director of marketing detection at Tecan Austria, said in a statement. "Combining JPT peptide microarrays with our Tecan HS 4800 Pro and HS 400 Pro hybridization stations for automated microarray processing will provide our customers with a new level of process standardization to maximize the value of their research."
Tecan, based in Männedorf, Switzerland, provides laboratory instruments and solutions to the biopharmaceutical, forensics, and clinical diagnostics markets. Based in Berlin, JPT is a wholly owned subsidiary of BioNTech and provides services and tools for peptide-related projects.